‘Platform-as-a-Service’ (PaaS) offers IT efficiencies especially for emerging biopharma
Just as biopharma companies are growing more comfortable with software-as-a-service (SaaS) for customer-relationship management, accounting and other IT functions, now it is being offered “IT in a box” to have a preconfigured, validated IT infrastructure through a managed services agreement (MSA). Such MSAs are an increasingly common feature of the IT industry, but the innovation here is to structure the MSA specifically for biopharma needs.
“We’ve been offering various types of managed services, such as handling corporate e-mail, disaster recovery and others for quite a while,” says John Biglin, CEO of Interphase Systems (Plymouth Meeting, PA). “We’ve realized that there is value in bundling all these capabilities as one offering, which we call Ready-IT BioPharma.”
Ready-IT is structured a la carte to meet various IT requirements in biopharma, including CRM, ERP, voice and data communications, disaster recovery and regulatory compliance. The company has also offered a tailored corrective-and-preventive-action (CAPA) managed service for handling FDA compliance issues. Interphase is most familiar with Microsoft-based enterprise tools, but some IT applications are defined by user requirements. Biglin says that although the service is most suitable for small to mid-size biopharma companies, Interphase has worked with several Big Pharma firms on specific IT applications. “Small to mid-size companies need to have industrial-strength IT infrastructures, but often don’t want to tie up capital or management resources in building their own systems,” he says.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.